Page last updated: 2024-08-26

1-methyltryptophan and Urinary Bladder Neoplasms

1-methyltryptophan has been researched along with Urinary Bladder Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chu, CE; Grossfeld, GD; Meng, MV; Porten, SP1
Brito, RBO; Camacho, CP; Dalmazzo, SV; de Almeida, RJ; DellĂȘ, H; Matheus, LHG; Pereira, LA1
Chen, YL; Huang, TT; Lai, MD; Lin, CC; Lin, CM; Weng, TY; Wu, CL; Yang, HJ; Yen, MC1

Reviews

1 review(s) available for 1-methyltryptophan and Urinary Bladder Neoplasms

ArticleYear
Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer.
    The Urologic clinics of North America, 2020, Volume: 47, Issue:1

    Topics: Acetamides; Administration, Intravesical; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Neoplasm Invasiveness; Oximes; Quinolines; Salvage Therapy; Sulfonamides; Treatment Outcome; Tryptophan; Tryptophan Oxygenase; Urinary Bladder Neoplasms

2020

Other Studies

2 other study(ies) available for 1-methyltryptophan and Urinary Bladder Neoplasms

ArticleYear
1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
    BMC cancer, 2020, Sep-09, Volume: 20, Issue:1

    Topics: Aged; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Middle Aged; Receptors, Aryl Hydrocarbon; Signal Transduction; Tryptophan; Urinary Bladder Neoplasms

2020
A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.
    Experimental biology and medicine (Maywood, N.J.), 2010, Volume: 235, Issue:7

    Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Liver Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Mice, Inbred NOD; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase; Piperidines; Tryptophan; Urinary Bladder Neoplasms

2010